ebrotidine and isradipine
ebrotidine has been researched along with isradipine in 3 studies
Research
Studies (3)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (66.67) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors
Authors | Studies |
---|---|
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Liu, J; Piotrowski, J; Slomiany, A; Slomiany, BL | 1 |
Czajkowski, A; Liu, J; Piotrowski, J; Slomiany, A; Slomiany, BL; Yotsumoto, F | 1 |
Reviews
1 review(s) available for ebrotidine and isradipine
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Other Studies
2 other study(ies) available for ebrotidine and isradipine
Article | Year |
---|---|
Inhibition of EGF-induced gastric mucosal calcium channel phosphorylation by ebrotidine.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Anti-Ulcer Agents; Benzenesulfonates; Calcium Channels; Calcium Radioisotopes; Epidermal Growth Factor; Gastric Mucosa; Isradipine; Phosphorylation; Phosphotyrosine; Rats; Thiazoles; Tyrosine | 1992 |
Regulation of gastric mucosal calcium channel activity by an antiulcer agent, ebrotidine.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Anti-Ulcer Agents; Benzenesulfonates; Calcium; Calcium Channels; Calcium Radioisotopes; Epidermal Growth Factor; Gastric Mucosa; Histamine H2 Antagonists; Isradipine; Liposomes; Male; Membranes; Phosphorylation; Rats; Rats, Sprague-Dawley; Thiazoles | 1994 |